105
0
0
Like?
Please wait...
About This Project
BioPeers – Peers Center for Biotech and Society
Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
Browse Other Projects on Experiment
Related Projects
Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration
Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
Open Insulin
A team of biohackers is developing the first open source protocol to produce insulin simply and economically...